Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 790

1.
2.

Conquering the intolerable burden of malaria: what's new, what's needed: a summary.

Breman JG, Alilio MS, Mills A.

Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):1-15. Review.

PMID:
15331814
3.

Deployment of ACT antimalarials for treatment of malaria: challenges and opportunities.

Whitty CJ, Chandler C, Ansah E, Leslie T, Staedke SG.

Malar J. 2008 Dec 11;7 Suppl 1:S7. doi: 10.1186/1475-2875-7-S1-S7. Review.

4.

Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries.

O'Connell KA, Gatakaa H, Poyer S, Njogu J, Evance I, Munroe E, Solomon T, Goodman C, Hanson K, Zinsou C, Akulayi L, Raharinjatovo J, Arogundade E, Buyungo P, Mpasela F, Adjibabi CB, Agbango JA, Ramarosandratana BF, Coker B, Rubahika D, Hamainza B, Chapman S, Shewchuk T, Chavasse D.

Malar J. 2011 Oct 31;10:326. doi: 10.1186/1475-2875-10-326.

5.

Anti-malarial market and policy surveys in sub-Saharan Africa.

Diap G, Amuasi J, Boakye I, Sevcsik AM, Pecoul B.

Malar J. 2010 Apr 23;9 Suppl 1:S1. doi: 10.1186/1475-2875-9-S1-S1.

6.

Artemisinin-based combination therapy for uncomplicated malaria in sub-Saharan Africa: the efficacy, safety, resistance and policy implementation since Abuja 2000.

Ogbonna A, Uneke CJ.

Trans R Soc Trop Med Hyg. 2008 Jul;102(7):621-7. doi: 10.1016/j.trstmh.2008.03.024. Epub 2008 May 21. Review.

PMID:
18499204
7.

Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.

Dodoo AN, Fogg C, Asiimwe A, Nartey ET, Kodua A, Tenkorang O, Ofori-Adjei D.

Malar J. 2009 Jan 5;8:2. doi: 10.1186/1475-2875-8-2.

8.

A major transition in malaria treatment: the adoption and deployment of artemisinin-based combination therapies.

Bosman A, Mendis KN.

Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):193-7. Review.

PMID:
18165492
9.

Artemisinin-based combination treatment of falciparum malaria.

Nosten F, White NJ.

Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):181-92. Review.

PMID:
18165491
10.

A situational analysis of pharmacovigilance plans in the Global Fund Malaria and U.S. President's Malaria Initiative proposals.

Stergachis A, Bartlein RJ, Dodoo A, Nwokike J, Kachur SP.

Malar J. 2010 May 30;9:148. doi: 10.1186/1475-2875-9-148.

11.

Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: case studies of South Africa, Zambia and Ethiopia.

Barnes KI, Chanda P, Ab Barnabas G.

Malar J. 2009 Oct 12;8 Suppl 1:S8. doi: 10.1186/1475-2875-8-S1-S8. Review.

12.

Subsidising artemisinin-based combination therapy in the private retail sector.

Opiyo N, Yamey G, Garner P.

Cochrane Database Syst Rev. 2016 Mar 9;3:CD009926. doi: 10.1002/14651858.CD009926.pub2. Review.

14.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
15.

[Subsidized artemisinin based combination treatments for Africa].

Fandeur T, Abani M.

Med Mal Infect. 2010 Nov;40(11):611-6. doi: 10.1016/j.medmal.2010.07.002. Epub 2010 Nov 3. Review. French.

PMID:
21051164
16.
17.

A threshold analysis of the cost-effectiveness of artemisinin-based combination therapies in sub-saharan Africa.

Coleman PG, Morel C, Shillcutt S, Goodman C, Mills AJ.

Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):196-204.

PMID:
15331838
18.

Access to artemisinin-combination therapy (ACT) and other anti-malarials: national policy and markets in Sierra Leone.

Amuasi JH, Diap G, Nguah SB, Karikari P, Boakye I, Jambai A, Lahai WK, Louie KS, Kiechel JR.

PLoS One. 2012;7(10):e47733. doi: 10.1371/journal.pone.0047733. Epub 2012 Oct 25.

19.

[Malaria research for developing countries: the PAL+ program].

Agid F.

Med Trop (Mars). 2003;63(3):236-40. French.

PMID:
14579458
20.

How artemisinin-containing combination therapies slow the spread of antimalarial drug resistance.

Hastings I.

Trends Parasitol. 2011 Feb;27(2):67-72. doi: 10.1016/j.pt.2010.09.005.

PMID:
20971040

Supplemental Content

Support Center